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Inevitably, most discussion of bioethical issues concerning infectious disease has 
concentrated on disease in humans.  However, disease in wildlife raises a number of 
important ethical questions that have not been widely considered. For several reasons, this is 
an important omission.  Wildlife diseases are of direct concern to human well-being.  Almost 
all emerging diseases of humans are zoonotic: that is, they occur in humans by cross-species 
transmission from an animal host 1,2.  Examples of current interest include Ebola virus, which 
appears to have transferred to humans from the great apes in East Africa 3, HIV, which 
appears to have taken a similar route into the human population 4, SARS, which appears to 
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have a variety of wild mammalian hosts in southern China 5, and avian influenza, which 
occurs in wild waterfowl and is transferred to humans by domestic poultry 6.  Wildlife 
diseases may also be of significance to domestic stock. For example, bovine tuberculosis is a 
major problem in the dairy industry and is thought to have wildlife as reservoirs 7,8 (badgers 
in the United Kingdom and brush tailed possums in New Zealand).  As well as these routes of 
transfer from wild populations to domestic animals or human populations, transfer may also 
occur in the reverse direction.  For example, the lion population in the Serengeti National 
Park is currently endangered by canine distemper which has been transferred to the lions 
from the domestic dog populations 9 and African wild  dogs are threatened with rabies, also 
transferred from domestic dogs10.  Finally, wildlife disease may be a significant threatening 
process to a number of endangered species 11. In this paper, we will discuss the ethical issues 
that each of these aspects of wildlife disease raises. 
 
First, however, we will briefly review some of the principles of epidemiology and control of 
infectious disease as these underlie most of the ethical issues that we will be discussing. A 
central concept in the control of infectious disease in any population is R0, or the basic 
reproductive rate of the disease 12, which is the number of secondary cases produced per 
primary case, when the disease is first introduced to a population. If this exceeds one then the 
disease will increase in the population. Otherwise, it will die out. Attempts to control disease 
in wildlife populations therefore concentrate on reducing R0 to below one. R0 can take various 
forms depending on the disease and its mode of transmission, but in general it is the infection 
rate per unit time, multiplied by the time infection persists in an infected individual. The 
infection rate per unit of time can be reduced by decreasing contacts between potential hosts 
by reducing overall host density (by culling), or by reducing the chance of disease 
transmission per contact by vaccination. The time infection persists in infected individuals 
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can be reduced either by treating the infection, or by removing infected individuals from the 
population by culling. These are principles common to disease in humans and domestic stock 
as well as wildlife. However, in free-ranging animal populations, the feasibility of potential 
control options is restricted compared to either domestic animals or humans. Treatment of 
infected individuals on a population scale is often impossible, as it involves capture, detection 
of infection, successful treatment and then release. Animal welfare groups attempt this, but it 
is rarely possible on a scale that will affect the dynamics of the disease in the population: it 
may alleviate suffering in individual animals, and may satisfy the wildlife carer, but is 
unlikely to prevent or slow the rate of progress of an epidemic. Release of animals that have 
spent time in close association with humans (and often with animals of other species: wildlife 
carers in Australia seem to maintain veritable menageries) may have substantial negative 
impacts on the wild population, including cross-species disease transmission and disruption 
of social structure. 
Vaccination is similarly a disease management strategy that is difficult to apply to wildlife 
relative to domestic animals or humans, although there have been some notable successes. 
For example, wild foxes in Europe are vaccinated against rabies, as are raccoons in the NE 
USA (to prevent zoonotic disease in humans) by distribution of oral vaccine in chicken heads 
or prepared baits 13. Although a high proportion of the target is successfully vaccinated, many 
of the baits are taken by non-target species. As the rabies vaccine is a recombinant self 
replicating entity, this does raise ethical questions concerning potential hazards to other 
species14, but rabies is such a severe threat to human health that broad scale distribution of 
the oral vaccine is widely used as a control strategy. 
Given the difficulty in wildlife of applying the treatment and vaccination options (which are 
the main strategies used in disease control within human populations), control of disease in 
wildlife tends to concentrate on culling, with the objective of either reducing transmission 
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rates through reducing host density, or of reducing the time infected animals remain able to 
infect other animals. Culling is, of course, entirely unethical in human populations, but is 
very widely applied to control disease in domestic stock. A recent example is the large scale 
culling used in the British foot and mouth disease epidemic 15. This did itself raise serious 
ethical issues in relation to both animal welfare issues and the impact on farmers. However, 
culling wildlife raises a range of issues additional to those in domestic stock. Some relate to 
the difficulty in humanely killing wild animals on a sufficiently large scale. More 
fundamentally, total extirpation of local populations is the explicit goal of culling programs to 
control disease in domestic stock. Re-establishing herds or flocks after an appropriate period 
is financially difficult but biologically straightforward. Total local extinction of any wildlife 
population is more problematical, as reintroduction is difficult and often (perhaps even 
usually) fails 16 
 
Zoonotic disease 
We have already mentioned a number of diseases of humans that are transferred from 
animals. Control of many of these is attempted by culling the animal populations that are 
thought to be the reservoirs of the disease in question. This raises obvious ethical problems in 
weighing the potential benefit to humans against the negative consequences, both in terms of 
suffering and conservation impact, to the animal population. Whilst many would argue that 
human welfare must be paramount, mere identification of an animal as a reservoir host of a 
human pathogen is not sufficient reason to cull those animals. For example, whilst it is fairly 
clear that the proximate animal reservoirs involved in transferring Ebola to the human 
population are the great apes (Gorillas and Chimpanzees) 3, few would argue that culling 
these animals is an appropriate or ethical response.  
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Flying foxes have been implicated as the reservoirs for three fatal diseases of humans in 
Australia and South East Asia: Nipah virus 17, Hendra virus 18 and bat Lyssavirus 19. 
However, these bats are protected species in Australia. Any attempt to control these diseases 
through large-scale culling would therefore introduce a conflict between conservation and 
human health. Determining where the balance between these two goals ought to be struck 
raises difficult ethical questions. Even from a purely human-centred perspective, flying foxes 
are important pollinators and seed dispersers, so reductions in their numbers might have 
substantial negative consequences for human welfare. Fortunately, in Australia at least, Lyssa 
virus and Hendra virus remain very rare indeed in the human population, despite high levels 
of seropositivity (which indicates previous exposure to the viruses) in bat populations. These 
emerging diseases are therefore more appropriately managed through reducing those bat-
human contacts that might result in transfer of infection rather than through trying to 
eliminate or reduce bat populations. 
Wildlife as reservoirs for disease of domestic animals 
As with human zoonotic disease, a standard response to wildlife reservoirs of disease in 
domestic stock is to suggest culling of the wildlife population.  In some cases, culling may 
even be counterproductive.  One example is the practice in Britain of culling badger 
populations in order to reduce transmission of bovine tuberculosis to dairy herds 8.  A large 
scale experimental study found that removal of badgers had the paradoxical effect of 
increasing transmission to cattle 20.  Badgers are a strongly territorial animal and removal of 
some members of the population caused increased rates of movement amongst the remaining 
animals as they sought to establish territories in the areas vacated by animals that have been 
removed.  The effect of this increased movement was to increase the rate at which the 
pathogens were transmitted.  
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In many other cases where domestic animals and wildlife share pathogens, it is unclear 
whether the wildlife are reservoirs for infection that then “spills over” into the domestic 
animals, or whether the reverse is the case 1. 
Infectious disease and conservation. 
Again, culling is a central issue when considering control of disease in populations of 
conservation significance.  For example, Tasmanian devils are currently affected by a facial 
tumour disease that appears to be infectious, and which has greatly reduced populations in 
some areas to the extent that the survival of some populations is in doubt21. At this stage, 
there is no known treatment, nor is the identity of the agent known. One of the only possible 
control strategies is to cull animals. One option would be to remove all diseased animals, but 
it might even be advisable to remove all animals from infected areas, in an approach 
analogous to that used for domestic stock infected by foot and mouth disease. Determining 
when or whether it is ethically appropriate to cull a species of special conservation 
significance, in the face of a great deal of uncertainty concerning whether such a strategy 
would even be successful is a daunting issue.  
There are also many ethical issues associated with attempting to treat or vaccinate wild 
populations of a rare species.  An example is the case of the African wild dog which is a 
critically endangered species and is threatened in some areas by rabies infection 22.  There has 
been a continuing controversy over whether it is appropriate to catch wild animals and 
vaccinate them against rabies, with suggestions being made that the process of capture and 
handling of the animals itself leads to disappearance of entire packs 23,24. 
Use of Infectious Disease to Control Pest Populations 
One of the potentially most difficult ethical issues in wildlife disease concerns the use of 
infectious disease as a biological control agent. The best-known current example of this is the 
use of myxomatosis 25 and more recently rabbit haemorrhagic disease 26 to control rabbit 
 7
populations in Australia, New Zealand and Europe.  In these cases, the ethical issues involve 
balancing of any benefits to agricultural production and biodiversity conservation with the 
undoubted animal welfare issues associated with introducing a pathogen which leads to the 
prolonged and probably painful death in the rabbits. 
 However, there are more significant ethical issues associated with the proposed use of 
genetically modified pathogens to control the vertebrate pest populations. In Australia, such 
agents are in the process of being developed for rabbits, house mice and European foxes 27,28 .  
In New Zealand, research is currently in progress to develop agents to control Australian 
brush tail Possum populations 29.  There have also been some suggestions that it may be 
possible to develop such agents to control kangaroo populations in Australia.  Most of these 
programs involve so-called "immunocontraceptive" technologies, in which the objective is to 
engineer a transmissible agent so that it effectively sterilises the target species 30-32.  This 
should then eliminate some of the animal welfare issues associated with lethal control, and in 
fact this technology has been seized upon and advocated by elements of the animal welfare 
lobby in Australia 33.  However, it raises a range of additional ethical issues, including the 
general principle of whether it is wise to release genetically modified infectious agents into 
the environment and also the possibility that such agents may affect species other than those 
targeted, either within the same region in which the release takes place or, in the case of 
brush tail possums in New Zealand, by transfer of the pathogens from the region in which it 
has been released to a region in which the target species is not a pest. 
 
Constructing a legal framework for ethical issues in wildlife disease. 
 
As Michael Selgelid34 has noted, there appears to be an attention deficit in bioethics with 
respect to infectious disease. By this view, other high-profile topics have dominated the 
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bioethics literature; particularly abortion, stem cell research, cloning, euthanasia, etc – with 
comparatively little attention paid to infectious disease despite its history of human 
destruction. 
 
If there is a deficit in the bioethics literature there is a comparable deficit in the legal domain. 
While Flood and Williams 35 have made major contributions from Canada, as has Gostin 36 
from the United States, there is as yet an undeveloped legal literature in the infectious disease 
context in many other jurisdictions. In Australia, recent contributions have been made by 
Bennett in the context of responses to human infectious diseases such as SARS, and by 
McSherry37 in the context of responses to detention in related situations such as that of 
predisposition toward “dangerousness.”  There is as yet little written on the area of legal 
responses to infectious disease in wildlife populations.  
 
The legal framework within which release of GMOs for control of wildlife in Australia would 
be regulated is provided by a range of intersecting acts. Federal 1984 (Cth) and State 
Biological Control Acts, once an agent is declared as a “biological control agent”, limit the 
capacity to sue to prevent release or to recover damages from the consequences of release. 
The federal Gene Technology Act 2000 (Cth) is the primary legislation regulating release of 
GMOs in Australia, and it is the Office of the Gene Technology Regulator established under 
this legislation which would ultimately be responsible for deciding whether such a release 
would be approved. Most of the species proposed to be controlled by GMO pathogens are 
listed as Key Threatening Processes under federal and state Biodiversity Conservation Acts. 
The Quarantine Act 1908 (Cth) as amended by the Quarantine Amendment (Health) Act 
2003, empowers quarantine officers, in the human context, to determine whether a person is, 
or is likely to be, infected with a quarantinable disease or quarantinable pest or a source of 
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infection with a quarantinable disease or quarantinable pest.  In making that determination 
they may seek the opinion of a medical practitioner and if they order a person into quarantine 
they must inform the person of the right to request an independent medical assessment.   The 
Act also provides powers to quarantine domestic stock or crops within Australia and to limit 
their import. What its implications might be for wildlife populations within Australia is less 
clear. Internationally, any release of a GMO biocontrol pathogen would have implications 
under the Cartegena Protocol on Biosafety38. However, Australia is not among the 119 
countries that have so far signed or ratified the protocol39. As far as we know, the Office of 
the Gene Technology Regulator has not been asked for, and nor has it yet provided, an 
advisory opinion on whether or under what conditions release of a GMO pathogen for 
biocontrol of vertebrates might be approved. 
Remedies 
Restrictions imposed by quarantine officers have been litigated in Australia as breaches of 
statutory duty and in negligence. An example of the former is Tilba Tilba Stud (WA) v 
Executive Officer of Agriculture Western Australia. 40  The action arose from a decision taken 
in October 1999 by a stock inspector with the Western Australian Department of Agriculture 
to issue a quarantine order under powers invested in him by statute. The order was issued 
after samples from two of the plaintiff’s rams tested positive to foot-rot disease. The property 
remained under quarantine until it was sold in May 2000. Some sheep were moved to another 
property and released from quarantine. The plaintiffs brought an action against the 
Department alleging that the quarantine order was negligently issued and maintained and that 
they suffered financial loss as a result. It was suggested that the breach of duty lay in the 
failure to exercise due diligence and to inform them of other viable alternatives to the 
quarantine, and in the insistence that the animals undergo foot bathing treatment. The action 
failed, suggesting that issues of proof in such cases will be particularly difficult for any 
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potential, aggrieved, plant and animal owners. Indeed, a counter-argument may arise in 
nuisance where property-owners refuse to comply with quarantine directives and hence 
contribute to persistence of the disease or pest.  
From the ethical perspective perhaps the most contentious dimension to control over 
emerging disease threats in the plant and animal context lies in the impact those controls may 
have on humans in transit. Restrictions on plant and animal movement need to be justified in 
terms that clearly distinguish them from humans seeking migration or refugee status. Yet in 
Australia in particular there has been an implicit form of analogous reasoning, with one 
politician inadvertently suggesting during the last election campaign that there was little 
difference between quarantining cats and dogs coming in from overseas and detaining asylum 
seekers. With an emphasis on national purity and security, the human welfare aspect is 
diminished. Ian Duncanson41 has explored the national anxieties that this mood articulates, 
and comments: 
‘Like the contemporaneous infections spreading across much of the world, “mad cow” 
disease and foot and mouth disease, against which Australia successfully quarantined 
itself, the asylum seekers are signifiers of the pollution of Australian purity, which is in 
need of defense”. 
Discussion and future directions 
One of the major general problems underlying all of the previous case studies is that there is 
currently no general ethical basis on which to make decisions regarding environmental or 
ecological ethics. Over the last few decades, many ethicists have moved beyond an entirely 
anthropocentric view of environmental ethics 42-44. Nevertheless, the extent to which humans 
might have duties towards populations, species and ecosystems, and the extent to which these 
entities might have rights beyond those of the individual organisms within them is debatable. 
As ecology (and epidemiology as a subset of ecology) is fundamentally concerned about 
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processes that arise at these higher levels of organisation, this is an important and unresolved 
issue, which is now receiving attention both from ecologists and ethicists 45. This problem is 
nowhere more evident than when considering wildlife disease, where issues of human health, 
animal welfare and ecological conservation intersect. 
 
Resolving ethical conflicts in this field, as in others, requires weighing up the consequences 
of alternative actions. A central feature of all ecological systems (and any host-pathogen 
interaction is essentially an ecological system) is the high level of intrinsic uncertainty 46,47. 
Not only do human welfare considerations need to be balanced against conservation and 
animal welfare, but the consequences in each of these dimensions of any given management 
action are uncertain. There are established ways in which uncertainty can be included in 
decision making 48, but these require a common currency for all costs and benefits of 
alternative management actions. The contrasting and apparently incompatible dimensions of 
ethical considerations for human health, animal welfare and conservation make the 
application of such tools to wildlife disease extraordinarily challenging. 
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